熱門資訊> 正文
Telesis Bio将其证券从纳斯达克退市
2024-09-11 04:45
- Telesis Bio (NASDAQ:TBIO) said on Tuesday that it has notified Nasdaq of its decision to delist the company’s shares of common stock.
- Telesis expects that the last trading day of its common stock on the Nasdaq Global Select Market will be on or about September 30, 2024.
- Telesis had received a letter in April from the listings department of Nasdaq notifying that the company was not in compliance with the minimum stockholder’s equity requirement which requires companies listed on the Nasdaq Global Select Market to maintain a minimum of $10M in stockholders' equity for continued listing.
- Telesis Bio (TBIO) believes that it will be unable to regain compliance with the Stockholders’ Equity Requirement, and thus has decided to voluntarily delist from Nasdaq.
More on Telesis Bio
- Seeking Alpha’s Quant Rating on Telesis Bio
- Historical earnings data for Telesis Bio
- Financial information for Telesis Bio
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
